PARP inhibitors in epithelial ovarian cancer: what are their potential implications for surgical management?

被引：2
|
作者：
Peters, Inge [1 ,2 ]
Marchetti, Claudia [1 ,2 ]
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Womans & Child Hlth & Publ Hlth Sci, Gynecol Oncol Unit, I-00168 Rome, RM, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
EJSO | 2023年 / 49卷 / 09期
关键词：
Epithelial ovarian cancer; PARP inhibitors; Surgical management; Progression-free survival; Postoperative morbidity; PRIMARY SURGERY; OPEN-LABEL; CHEMOTHERAPY;
D O I：
10.1016/j.ejso.2023.06.025
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PARP Inhibitors in Epithelial Ovarian Cancer
    Taylor, Kristin N.
    Eskander, Ramez N.
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2018, 13 (02) : 145 - 158
  • [2] Non-surgical management of advanced ovarian cancer with maintenance PARP inhibitors
    Lantsman, Taliya
    Jia, Lily
    Shea, Meghan
    GYNECOLOGIC ONCOLOGY REPORTS, 2024, 52
  • [3] What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
    Joyce F. Liu
    Ursula A. Matulonis
    Current Oncology Reports, 2016, 18
  • [4] What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
    Liu, Joyce F.
    Matulonis, Ursula A.
    CURRENT ONCOLOGY REPORTS, 2016, 18 (05)
  • [5] The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
    Gien, Lilian T.
    Mackay, Helen J.
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [6] PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline
    Tew, William P.
    Lacchetti, Christina
    Ellis, Annie
    Maxian, Kathleen
    Banerjee, Susana
    Bookman, Michael
    Jones, Monica Brown
    Lee, Jung-Min
    Lheureux, Stephanie
    Liu, Joyce F.
    Moore, Kathleen N.
    Muller, Carolyn
    Rodriguez, Patricia
    Walsh, Christine
    Westin, Shannon N.
    Kohn, Elise C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (30) : 3468 - +
  • [7] Utilization of PARP inhibitors in the management of ovarian cancer in Nigeria
    Akinsanya, Precious
    Akahara, Darlington
    Okoro, Uchenna Samuel
    Okonkwo, Susan
    Umeh, Uchenna Anthony
    Lasebikan, Nwamaka
    Uche, Enoch
    Okafor, Adetoro
    Olusunmade, Oyindamola
    Okehi, Uchechi
    Julemis, Marsophia
    Orimaye, Sylvester
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [8] Surgical Management of Epithelial Ovarian Cancer
    Salani, Ritu
    Bristow, Robert E.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2012, 55 (01): : 75 - 95
  • [9] PARP Inhibitors in Ovarian Cancer
    Mittica, Gloria
    Ghisoni, Eleonora
    Giannone, Gaia
    Genta, Sofia
    Aglietta, Massimo
    Sapino, Anna
    Valabrega, Giorgio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2018, 13 (04) : 392 - 410
  • [10] PARP inhibitors in ovarian cancer
    David Cibula
    Judith Balmaña
    British Journal of Cancer, 2015, 113 : S1 - S2
12345